Hemp is a highly revered plant due to its unrivaled versatility. For many years it has been used as fiber, fuel, food and medicinal use. You can buy now online or through pharmacies. Many cultures associate the plant with unique healing powers. However, in the modern day world, the focus on hemp is driven by one of its essential compounds – cannabidiol or CBD.
This naturally occurring compound is used to produce excellent pharmaceutical products. Some of the popular drugs manufactured using CBD are poised for FDA approval in the treatment of conditions such as pediatric refractory epilepsy. Unfortunately, CBD alone is incapable of delivering a complete healing solution – proving an argument which suggests how limited the isolated active ingredient can be.
Isolated Active Ingredient vs. Plant-Based Model
The nutraceutical industry operates in a manner that likens the pharmaceutical model. The common attribute focusses on identifying how one molecule can be standardized after which it is studied to determine efficacy and safety. Some feel the fact the treatment model where a part of the active ingredient is delivered in a dose or serving is to ignore the entire point.
When administered as a regular pharmaceutical drug, we are ignoring the holistic benefits of plant-based medicines arising from the combination of the active ingredient alongside other essential molecules to produce the intended outcome. Usually, during extraction of the active ingredient, the manufacturers’ interests take precedence.
Only opt for those products developed for customers with a keen intention of delivering the benefits of the active and essential substance from the hemp plant. There is no single solution in the herbal or food supplement industry responsible for the plant health benefits. Medicinal plants have hundreds of active compounds interacting in synergy to achieve the desired health benefits.
More than CBD
A phenomenal study conducted in 2015 demonstrated superior therapeutically properties from whole hemp plant extracts as opposed to a single CBD molecule. The new development was published in the Journal of Pharmacology and Pharmacy, back in February 2015. The article was a direct challenge to the widely held assumption that big pharmaceutical solutions trump traditional allopathic medicine. The notions that crude botanical concoctions are less effective than artificially purified structural molecule formulations is incorrect.
Expert Research Backs Up Argument
The scientists who worked on the subject matter for over 15 years including several preclinical studies focusing on the anti-inflammatory results of pure or single molecule hemp extracts. The tests were centered on a condition such as rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, and diabetes.
The healing property manifested when CBD was delivered in a limited dose. Anything lower or higher produced on a beneficial result. The single CBD molecule has limited use when used in the clinical context. To overcome this limitation the team compared the effects from whole plant extracts containing CBD and a wide array of minor cannabinoids.
Concluding Consensus
It was established that mice given the whole plant CBD extracts showed a direct, pain inhibition and inflammation. A bell-shaped curve appeared that was a direct correlation between anti-inflammatory and anti-nociceptive response to this dose. In summary, when using the whole plant extract, a smaller amount is required to achieve the same effect of the pure CBD.
